Home › Funds › Patient Capital Management, LLC › QXO

Patient Capital Management, LLC position in QXO

QXO INC · Consumer Discretionary

Patient Capital Management, LLC reported holding 10,932,468 shares of QXO (QXO INC) in its Q3 2026 13F filing — a position valued at US$127.8M, representing 4.32% of its reported portfolio and ranking #8 among its reported holdings. Patient Capital Management, LLC has disclosed QXO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)10.93M sh
Reported value held$127.80M
Portfolio Weight4.32%
First reportedQ3 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's QXO position evolved

Patient Capital Management, LLC first disclosed a stake in QXO in Q3 2024 at 7,741,847 shares (US$122.1M). The position peaked in Q2 2025 at 6,542,202 shares, worth US$140.9M. Across 9 filings, Patient Capital Management, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,932,468 shares valued at US$127.8M — an increase of 3,795,799 shares quarter over quarter.. Notable position changes include a 53% increase in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 7.74M $122.09M New
Q4 2024 7.73M $122.96M Hold
Q1 2025 7.28M $98.64M Reduce
Q2 2025 6.54M $140.92M Reduce
Q3 2025 6.54M $124.60M Hold
Q4 2025 6.47M $124.78M Reduce
Q1 2026 6.78M $131.64M Add
Q2 2026 7.14M $123.32M Add
Q3 2026 10.93M $127.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QXO and 13F data

QXO (QXO INC) is a Consumer Discretionary company. 48 other funds we track also report a position in QXO — the largest reported positions include Orbis Allan Gray Ltd (US$1.28B), Baillie Gifford & Co (US$544.0M), FRED ALGER MANAGEMENT, LLC (US$472.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QXO

All QXO fund holders →

FAQ

How long has Patient Capital Management, LLC held QXO?

Patient Capital Management, LLC has disclosed QXO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Patient Capital Management, LLC's current position in QXO?

As of Q3 2026, Patient Capital Management, LLC holds 10.93M shares of QXO (QXO INC), valued at $127.80M, representing 4.32% of its reported portfolio and ranking #8.

Has Patient Capital Management, LLC been buying or selling QXO?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC increased its position in QXO. The position peaked in Q2 2025 at 6.54M shares.

Which other funds hold QXO?

Other major institutional holders of QXO include Orbis Allan Gray Ltd, Baillie Gifford & Co, FRED ALGER MANAGEMENT, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.